Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity

Laetitia Vanderijst, Jean-Luc Faillie, Thibault Mura, Amandine Luquiens

Open source

DOI
10.1016/j.drugpo.2026.105423
Published
2026-09
Container
International Journal of Drug Policy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drugpo.2026.105423,
  title = {Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity},
  author = {Laetitia Vanderijst and Jean-Luc Faillie and Thibault Mura and Amandine Luquiens},
  year = {2026},
  journal = {International Journal of Drug Policy},
  doi = {10.1016/j.drugpo.2026.105423},
  url = {https://doi.org/10.1016/j.drugpo.2026.105423}
}

RIS

TY  - JOUR
TI  - Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity
AU  - Laetitia Vanderijst
AU  - Jean-Luc Faillie
AU  - Thibault Mura
AU  - Amandine Luquiens
PY  - 2026
JO  - International Journal of Drug Policy
DO  - 10.1016/j.drugpo.2026.105423
UR  - https://doi.org/10.1016/j.drugpo.2026.105423
ER  - 

APA

Vanderijst, L., Faillie, J., Mura, T., & Luquiens, A. (2026). Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2026.105423

Source records